Your browser doesn't support javascript.
loading
Epigenetically altered miR-193b targets cyclin D1 in prostate cancer.
Kaukoniemi, Kirsi M; Rauhala, Hanna E; Scaravilli, Mauro; Latonen, Leena; Annala, Matti; Vessella, Robert L; Nykter, Matti; Tammela, Teuvo L J; Visakorpi, Tapio.
Affiliation
  • Kaukoniemi KM; Institute of Biosciences and Medical Technology - BioMediTech, University of Tampere, Tampere, Finland.
  • Rauhala HE; Fimlab Laboratories, Tampere University Hospital, Tampere, Finland.
  • Scaravilli M; Institute of Biosciences and Medical Technology - BioMediTech, University of Tampere, Tampere, Finland.
  • Latonen L; Institute of Biosciences and Medical Technology - BioMediTech, University of Tampere, Tampere, Finland.
  • Annala M; Fimlab Laboratories, Tampere University Hospital, Tampere, Finland.
  • Vessella RL; Institute of Biosciences and Medical Technology - BioMediTech, University of Tampere, Tampere, Finland.
  • Nykter M; Fimlab Laboratories, Tampere University Hospital, Tampere, Finland.
  • Tammela TL; Institute of Biosciences and Medical Technology - BioMediTech, University of Tampere, Tampere, Finland.
  • Visakorpi T; Department of Urology, University of Washington, Seattle, Washington.
Cancer Med ; 4(9): 1417-25, 2015 Sep.
Article in En | MEDLINE | ID: mdl-26129688

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Gene Expression Regulation, Neoplastic / Cyclin D1 / MicroRNAs / RNA Interference / Epigenesis, Genetic Limits: Humans / Male Language: En Journal: Cancer Med Year: 2015 Type: Article Affiliation country: Finland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Gene Expression Regulation, Neoplastic / Cyclin D1 / MicroRNAs / RNA Interference / Epigenesis, Genetic Limits: Humans / Male Language: En Journal: Cancer Med Year: 2015 Type: Article Affiliation country: Finland